Sarah Kidd1, Page C Moore, Robert D Kirkcaldy, Susan S Philip, Harold C Wiesenfeld, John R Papp, Peter R Kerndt, Lalitha Venkatasubramanian, Khalil G Ghanem, Edward W Hook. 1. From the *Centers for Disease Control and Prevention, Atlanta, GA; †University of Arkansas for Medical Sciences, Little Rock, AR; ‡San Francisco Department of Health, San Francisco, CA; §University of Pittsburgh and Allegheny County Health Department, Pittsburgh, PA; ¶County of Los Angeles, Department of Public Health, Los Angeles, CA; ∥FHI360, Durham, NC; **Johns Hopkins University School of Medicine, Baltimore, MD; and ††University of Alabama at Birmingham and Jefferson County Department of Health, Birmingham, AL.
Abstract
BACKGROUND: The US system for gonococcal antimicrobial susceptibility surveillance monitors trends exclusively among men with urethral infection, the population from whom the yield of gonococcal culture is highest. Little is known about the susceptibility of female urogenital isolates, and it is unclear whether gonococcal susceptibility among men who report sex exclusively with women (MSW) is representative of susceptibility among women. METHODS: Using isolates collected during a recent treatment trial in 5 US cities, we performed a secondary analysis to compare antimicrobial susceptibilities of Neisseria gonorrhoeae urogenital isolates obtained from women, MSW, and men who have sex with men (MSM). Pretreatment isolates were collected from trial participants; minimum inhibitory concentrations (MICs) were determined by agar dilution. Geometric mean MICs were adjusted for geographic location using general linear models. RESULTS: Susceptibility data for urogenital isolates from 56 women, 252 MSW, and 170 MSM were studied. The adjusted geometric mean ceftriaxone MIC was similar among women (0.0067 μg/mL; 95% confidence interval [CI], 0.0049-0.0092 μg/mL) and MSW (0.0060 μg/mL; 95% CI, 0.0053-0.0066 μg/mL). In contrast, the adjusted geometric mean ceftriaxone MIC was higher among MSM (0.0098 μg/mL; 95% CI, 0.0082-0.0119 μg/mL) than among MSW. This same pattern was observed for other antimicrobials, including cefixime and azithromycin CONCLUSIONS: Ceftriaxone, cefixime, and azithromycin MICs were higher among MSM than among MSW, but were similar among women and MSW. These findings suggest that gonococcal antimicrobial susceptibility surveillance based on urethral isolates from MSW may adequately represent susceptibility of urogenital N. gonorrhoeae in women.
BACKGROUND: The US system for gonococcal antimicrobial susceptibility surveillance monitors trends exclusively among men with urethral infection, the population from whom the yield of gonococcal culture is highest. Little is known about the susceptibility of female urogenital isolates, and it is unclear whether gonococcal susceptibility among men who report sex exclusively with women (MSW) is representative of susceptibility among women. METHODS: Using isolates collected during a recent treatment trial in 5 US cities, we performed a secondary analysis to compare antimicrobial susceptibilities of Neisseria gonorrhoeae urogenital isolates obtained from women, MSW, and men who have sex with men (MSM). Pretreatment isolates were collected from trial participants; minimum inhibitory concentrations (MICs) were determined by agar dilution. Geometric mean MICs were adjusted for geographic location using general linear models. RESULTS: Susceptibility data for urogenital isolates from 56 women, 252 MSW, and 170 MSM were studied. The adjusted geometric mean ceftriaxone MIC was similar among women (0.0067 μg/mL; 95% confidence interval [CI], 0.0049-0.0092 μg/mL) and MSW (0.0060 μg/mL; 95% CI, 0.0053-0.0066 μg/mL). In contrast, the adjusted geometric mean ceftriaxone MIC was higher among MSM (0.0098 μg/mL; 95% CI, 0.0082-0.0119 μg/mL) than among MSW. This same pattern was observed for other antimicrobials, including cefixime and azithromycin CONCLUSIONS:Ceftriaxone, cefixime, and azithromycin MICs were higher among MSM than among MSW, but were similar among women and MSW. These findings suggest that gonococcal antimicrobial susceptibility surveillance based on urethral isolates from MSW may adequately represent susceptibility of urogenital N. gonorrhoeae in women.
Authors: Lindsey Harryman; Sara Scofield; John Macleod; David Carrington; O Martin Williams; Arnold Fernandes; Paddy Horner Journal: Sex Transm Infect Date: 2011-10-27 Impact factor: 3.519
Authors: Heidi M Bauer; Karen E Mark; Michael Samuel; Susan A Wang; Penny Weismuller; Douglas Moore; Robert A Gunn; Chris Peter; Ann Vannier; Nettie DeAugustine; Jeffrey D Klausner; Joan S Knapp; Gail Bolan Journal: Clin Infect Dis Date: 2005-08-12 Impact factor: 9.079
Authors: Travis S Hottes; Richard T Lester; Linda M N Hoang; Rachel McKay; Miguel Imperial; Mark Gilbert; David Patrick; Tom Wong; Irene Martin; Gina Ogilvie Journal: Sex Transm Dis Date: 2013-01 Impact factor: 2.830
Authors: Robert D Kirkcaldy; Monina G Bartoces; Olusegun O Soge; Stefan Riedel; Grace Kubin; Carlos Del Rio; John R Papp; Edward W Hook; Lauri A Hicks Journal: Emerg Infect Dis Date: 2017-10 Impact factor: 6.883
Authors: Jesse L Clark; Eddy R Segura; Catherine E Oldenburg; Jessica Rios; Silvia M Montano; Amaya Perez-Brumer; Manuel Villaran; Jorge Sanchez; Thomas J Coates; Javier R Lama Journal: BMC Med Date: 2017-05-04 Impact factor: 8.775